Tenderwize
Back to tender search

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Naloxegol, ATC A06AH03 für die Zeit 01.08.2026 - 31.07.2028

DAK-GesundheitHamburg, GermanyEUR 1 / ~EUR 1721 days leftopen
60

Opportunity Score

Confidence: 65%

Complexity: low

721 days

Deadline

supplies

Contract

Deep Portfolio Analysis

  • Company fit score
  • Missing certificates
  • Eligibility blockers
  • Bid / No-Bid recommendation
Create account for AI analysis

AI Analysis Summary

Moderate opportunity

Non-exclusive discount agreement (Rabattvereinbarung) for the active substance Naloxegol (ATC A06AH03) under § 130a Abs. 8 SGB V. This is an open-house procedure (Zulassungsmodell), not a formal procurement. The contract period is 01.08.2026 - 31.07.2028. Any pharmaceutical company can join at any time by submitting the required documents via email. The estimated value is set at 1 EUR, which appears to be a placeholder. The deadline for initial enrollment is 05.06.2028, but rolling admissions apply.

Strengths

Documents available

Open procedure

Low complexity

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

  • Submit the required documents via email to [email protected].
  • Documents include: signed offer letter, acceptance of contract terms with agreed discounts, completed Annexes 1 and 2 (Annex 2 as Excel file).
  • Submission deadline for initial accession: 05.06.2028 (rolling admissions thereafter with 5th of previous month cut-off).

Buyer

Name

DAK-Gesundheit

Location

Hamburg, DEU

Website

www.dak.de

Identifier

DE48698890

Lots (1)

#LOT-0001Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Naloxegol, ATC A06AH03 für die Zeit 01.08.2026 - 31.07.2028

Single lot covering all pharmaceutical products containing Naloxegol. The agreement allows any interested company to join on equal terms. The contract automatically ends when an exclusive agreement is concluded for the same active substance.

EUR 133600000DEU

Procurement Details

Publication

14 Jun 2026

Deadline

05 Jun 2028, 10:00

Procedure

open

Contract

supplies

Duration

24 MONTH

Language

DEU

Publication #

407721-2026

Classification

Performance: Germany

Documents (2)

Pharmaceutical products Tender in Germany | TED 407721-2026